SAN FRANCISCO, Jan. 31, 2018 /PRNewswire/ -- Invitae
Corporation (NYSE: NVTA), one of the fastest growing genetic
information companies, today announced that Sean George, chief executive officer of Invitae,
will participate in two upcoming investor conferences being held in
New York City.
Sean George will present at the
2018 BIO CEO & Investor Conference on Tuesday, February 13, 2018 at 10:00 a.m. Eastern / 7:00
a.m. Pacific. Additionally, Sean
George will participate in a fireside chat at the Leerink
Partners 7th Annual Global Healthcare Conference on Wednesday, February 14, 2018 at 10:30 a.m. Eastern / 7:30
a.m. Pacific.
The live webcasts of both conference presentations may be
accessed by visiting the investors section of the company's website
at ir.invitae.com. A replay of the webcasts will be available
shortly after the conclusions of the presentations and will be
archived on the company's website.
About Invitae
Invitae Corporation's (NYSE: NVTA)
mission is to bring comprehensive genetic information into
mainstream medical practice to improve the quality of healthcare
for billions of people. Specializing in genetic diagnostics in
clinical areas across all stages of life, Invitae is aggregating
the world's genetic tests into a single service with better
quality, faster turnaround time, and lower prices. The company
provides a variety of diagnostic tests with clinical utility in
preimplantation and carrier screening for inherited disorders,
miscarriage analysis, pediatric and developmental disorders,
neurological disorders, cardiovascular disorders, metabolic
disorders, and hereditary cancers. For more information, visit our
website at invitae.com.
Contact:
Kate McNeil
ir@invitae.com
347-204-4226
View original content with
multimedia:http://www.prnewswire.com/news-releases/invitae-to-participate-in-two-upcoming-investor-conferences-including-the-2018-bio-ceo--investor-conference-and-leerink-partners-7th-annual-global-healthcare-conference-300590800.html
SOURCE Invitae Corporation